You are here

Japan

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

Globe Newswire

Fri, 12/6/24 - 11:03 am

Teva Pharmaceutical

Bayer lands regional rights to aficamten in Japan deal with Cytokinetics

First Word Pharma

Tue, 11/19/24 - 11:20 am

hypertrophic cardiomyopathy

Astellas unveils new Japan site for cell therapy research arm Universal Cells, transferring 12 roles overseas

Fierce Biotech

Wed, 10/9/24 - 09:07 pm

Aurion launches eye disease cell therapy in its first market

Pharmaphorum

Wed, 09/25/24 - 11:42 am

bullous keratopathy

Eli Lilly's Alzheimer's drug approved in Japan

Reuters

Tue, 09/24/24 - 11:39 am

Alzheimer's disease

Jazz’s cannabidiol therapy flunks in Japanese Phase III trial

Clinical Trials Arena

Fri, 08/23/24 - 10:47 am

Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development

PR Newswire

Tue, 08/6/24 - 11:19 am

Pharmas form joint venture to jumpstart Japanese drug research

BioPharma Dive

Mon, 04/22/24 - 11:29 am

Sumitomo Mitsui Banking

AstraZeneca's phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan

Fierce Biotech

Fri, 02/2/24 - 11:53 am

clinical trials

Eisai files biliary tract cancer drug tasurgratinib in Japan

Pharmaphorum

Mon, 12/18/23 - 10:14 am

biliary tract cancer

Ascendis sells Japanese rights to Skytrofa and two other hormone drugs for $70M upfront

Fierce Biotech

Thu, 11/30/23 - 10:19 am

Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine

Reuters

Thu, 11/16/23 - 10:22 pm

Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen

Reuters

Tue, 09/26/23 - 10:23 am

Alzheimer's disease

SoftBank-backed Neumora Therapeutics aims to raise up to $264.8 mln in US IPO

NASDAQ

Tue, 09/12/23 - 10:44 am

Neumora Therapeuticsl

Daiichi Sankyo to close Japanese research and development subsidiary

Pharmaceutical Business Review

Tue, 08/8/23 - 10:17 am

Aslan sells Japanese rights to would-be Dupixent rival for $12M

Fierce Biotech

Thu, 06/22/23 - 10:41 pm

With skin in the game, Satsuma's partner offers buyout to get migraine spray to market

Fierce Biotech

Mon, 04/17/23 - 12:07 pm

Satsuma Pharmaceuticals

Shin Nippon Biomedical

Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan

Endpoints

Thu, 03/23/23 - 08:54 pm

drug manufacturing

Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand

Endpoints

Sun, 02/12/23 - 07:44 pm

Daiichi Sankyo to build Japan's first mRNA vaccine manufacturing facility — report

Endpoints

Wed, 02/8/23 - 10:58 pm

drug manufacturing

Pages